Case Report: A rare case of small bowel obstruction secondary to plasma cell myeloma
Arturo Bonometti(Humanitas University), Antonio Di Sabatino(University of Pavia), Luca Arcaini(University of Pavia), Alessandro Vanoli(University of Pavia), Mario Andrea Latorre(University of Pavia), Sara Fraticelli(Humanitas University), Marco Lucioni(University of Pavia), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Nicola Aronico, Claudio Salvatore Cartia(Istituti di Ricovero e Cura a Carattere Scientifico), Marco Paulli(University of Milan)
Cited by 1
Related Papers
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Decline with age of the respiratory chain activity in human skeletal muscle
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|1994|340
ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum
|American Journal Of Pathology|1998|275